Product image of Ondansetron Accord (Ondansetron) supplied by GNH India

Ondansetron Accord

Active Ingredient:
Ondansetron
Origin:
EU

Ondansetron Accord (Ondansetron)

Ondansetron, the active ingredient in Ondansetron Accord, is a 5-HT3 receptor antagonist presented as a strength/form for oral use. It treats nausea and vomiting associated with chemotherapy, radiotherapy, and surgery in adult and pediatric patients. GNH India supplies Ondansetron Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH India supplies Ondansetron Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Accord Healthcare B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ondansetron Accord is a selective 5‑HT3 receptor antagonist used in the management of nausea and vomiting pathways.

  • Chemotherapy‑induced nausea and vomiting: helps prevent and control acute and delayed episodes.
  • Radiation‑induced nausea and vomiting: reduces the frequency and severity of symptoms.
  • Post‑operative nausea and vomiting: decreases the incidence of nausea after surgery.
  • Hyper‑emesis gravidarum: may be used when conventional therapy is insufficient.
  • Nausea due to gastro‑intestinal disorders: provides symptomatic relief in selected cases.

How It Works

  • Ondansetron blocks the action of serotonin at peripheral and central 5‑HT3 receptors, particularly in the chemoreceptor trigger zone and vagal afferents of the gastrointestinal tract. This inhibition prevents the initiation of the vomiting reflex triggered by chemotherapeutic agents, radiation, or surgical stimuli, thereby reducing nausea and vomiting.

Side Effects

Common Side Effects

  • Headache: mild to moderate intensity.
  • Constipation: occasional bowel movement difficulty.
  • Diarrhoea: loose stools in some patients.
  • Fatigue: general tiredness.
  • Dizziness: transient light‑headedness.
  • Injection site pain: localized discomfort if administered intravenously.

Serious or Rare Side Effects

  • Cardiac arrhythmia: QT‑interval prolongation may occur.
  • Severe hypersensitivity: rash, itching, or anaphylaxis.
  • Serotonin syndrome: rare when combined with other serotonergic agents.
  • Hepatic dysfunction: elevated liver enzymes.
  • Vision changes: blurred vision or visual disturbances.
  • Neuroleptic malignant‑like syndrome: extremely rare neurological reaction.

Precautions & Warnings

Ondansetron should be used with caution in patients with known cardiac conduction abnormalities or electrolyte imbalances.

  • Cardiac monitoring: obtain baseline ECG in at-risk patients.
  • Electrolyte assessment: correct potassium or magnesium deficits before use.
  • Drug interactions: review concomitant medications for QT‑prolonging potential.
  • Pregnancy: weigh benefits against potential risks; use only if clearly needed.
  • Breastfeeding: consider infant exposure; monitor if administered to nursing mothers.
  • Store at ambient temperature: keep below 25 °C, protect from moisture and light in the original packaging.

Avoid Interactions

Ondansetron may interact with several drug classes, requiring careful review of a patient’s medication list.

Major Interactions (Avoid)

  • Anti‑arrhythmic agents (e.g., amiodarone, quinidine): increase risk of QT prolongation.
  • Certain antipsychotics (e.g., ziprasidone, haloperidol): additive effect on cardiac repolarization.
  • Macrolide antibiotics (e.g., erythromycin): may enhance QT‑interval changes.

Moderate Interactions (Monitor Closely)

  • Tricyclic antidepressants: potential for additive serotonergic activity.
  • Serotonergic agents (e.g., SSRIs, SNRIs, triptans): monitor for serotonin syndrome.
  • CYP3A4 inhibitors (e.g., ketoconazole): may increase ondansetron plasma levels.

Frequently Asked Questions

Ondansetron Accord is an antiemetic medication indicated to prevent and treat nausea and vomiting associated with chemotherapy, radiotherapy, surgery, and certain gastrointestinal conditions. It works by targeting the pathways that trigger the vomiting reflex, providing relief for patients undergoing these treatments.

Ondansetron selectively blocks serotonin (5‑HT3) receptors in the central nervous system and gastrointestinal tract. By inhibiting these receptors, it prevents the activation of the chemoreceptor trigger zone and vagal afferents that normally initiate the vomiting response, thereby reducing nausea and vomiting.

The appropriate dose of Ondansetron Accord is determined by the prescribing clinician based on the patient’s age, weight, clinical condition, and treatment setting. Healthcare professionals follow established guidelines and adjust the regimen to achieve optimal antiemetic control.

Ondansetron should be used during pregnancy only if the potential benefit justifies any potential risk to the fetus, and it is generally reserved for cases where alternative therapies are ineffective. While small amounts can pass into breast milk, the decision to breastfeed while on ondansetron should be made in consultation with a healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ondansetron belongs to the 5‑HT3 antagonist class, offering a targeted mechanism distinct from dopamine antagonists (e.g., metoclopramide) or antihistamines (e.g., diphenhydramine). It is often preferred for chemotherapy‑induced nausea due to its efficacy and lower risk of extrapyramidal side effects, though choice of therapy depends on the clinical scenario.

Store Ondansetron Accord at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and ensure the container is tightly closed to maintain stability.

Ondansetron Accord is typically administered orally in tablet form, though it may also be given intravenously or intramuscularly in clinical settings. The route and dosage are selected by the prescriber according to the patient’s condition and treatment protocol.

Serious risks include cardiac arrhythmias such as QT‑interval prolongation, severe allergic reactions, and rare cases of serotonin syndrome when combined with other serotonergic drugs. Patients should be monitored for any signs of cardiac discomfort, rash, or unusual neurological symptoms.

Ondansetron is contraindicated in individuals with known hypersensitivity to ondansetron or any component of the formulation. Caution is also advised for patients with congenital long QT syndrome or those taking other medications that significantly prolong the QT interval.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ondansetron

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT